Silver Spring, MD, United States of America

Wendell David Zollinger

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: US Government as Represented by the Secretary of the Army, U.S. Army Medical Research and Materiel Command, Other. Active years: 1987-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendell David Zollinger. Retrieved from https://idiyas.com/inventor/wendell-david-zollinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 199(Granted Patents)


Company Filing History:


Years Active: 1987-2016

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Wendell David Zollinger: An Innovative Mind Revolutionizing Industries

Introduction:

Throughout his career, Wendell David Zollinger has proven himself as a visionary inventor, exhibiting a remarkable ability to transform his ideas into practical inventions. With a strong innovative mindset, Zollinger has developed cutting-edge technologies that hold the potential to revolutionize various industries. His contributions have been widely acknowledged by his peers and have earned him eight patents to date. This article aims to shed light on Zollinger's latest patents, career highlights, collaborations, and his overall impactful journey in the world of innovation.

Latest Patents:

Zollinger's latest patents showcase his dedication towards improving public health and combating bacterial infections. The first of his recent patents is the "Meningococcal multivalent native outer membrane vesicle vaccine, methods of making, and use thereof.” This technology offers a vaccine composition comprising native outer membrane vesicles (NOMVs) derived from genetically modified strains. Such a vaccine provides protective immunity against meningococcal disease, particularly subtype B meningococcal disease.

Another notable patent innovation by Zollinger is the "Vaccine against Gram-negative bacterial infections." This vaccine is designed to actively immunize the host subject against Gram-negative bacterial infections and LPS-mediated pathology. By inducing the production of antibodies, it also enables passive immunization of a secondary subject. Meningococcal infections, among other Gram-negative bacterial infections, are effectively protected against by this revolutionary vaccine.

Career Highlights:

Wendell David Zollinger has excelled throughout his career, consistently pushing the boundaries of innovation. He has made significant contributions to academia, industry, and research institutions, including working with government entities like "The United States of America As Represented by the Secretary of" and other prestigious organizations. His career highlights reflect his passion for improving public health and developing novel solutions to significant challenges.

Collaborations:

Collaboration has played an instrumental role in Zollinger's journey as an innovator. Among his notable collaborators are Apurba K Bhattacharjee and Alan S Cross, who have undoubtedly contributed to the success of his patented inventions. By working with talented and like-minded individuals, Zollinger has been able to leverage shared expertise and accelerate his progress in driving innovation forward.

Conclusion:

Wendell David Zollinger's remarkable ability to translate his ideas into practical inventions has positioned him as a leading force in the field of innovation. Through his cutting-edge technologies, such as the meningococcal vaccine and the vaccine against Gram-negative bacterial infections, Zollinger has made significant strides towards revolutionizing various industries. His contributions have not only been recognized by his peers but hold the promise of making a lasting impact on public health. With the culmination of his patents and collaborations with esteemed individuals in his field, Zollinger's work continues to inspire and shape the future of innovative advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…